Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seroma 4 Melanoma 3 Postoperative Complications 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Stomach Neoplasms 1 Lymphoma, Follicular 1 Lymphocele 1 Lymphedema 1 Hemorrhage 1 Carcinoma, Squamous Cell 1 Bone Neoplasms 1 Anastomotic Leak 1

Interventions

Tranexamic Acid 13 Sodium Chloride 4 Misoprostol 4 Saline Solution 3 Enoxaparin 3 carbetocin 2 Tourniquets 2 Ringer's Lactate 2 Oxytocin 2 Endoscopic Mucosal Resection 2 Dalteparin 2 Aspirin 2 maleimide-polyethylene glycol-modified hemoglobin, MP4 1 bemiparin 1 Vitamin B 6 1 Vasopressins 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Ultrasonography 1 Tinzaparin 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemorrhage × Fibrin Tissue Adhesive × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡